enVVeno Medical Corporation
Irvine
About enVVeno Medical Corporation
Hancock Jaffe Laboratories develops life-enhancing bioprosthetic devices and technologies intended to achieve unparalleled outcomes for patients with debilitating cardiovascular diseases. Each device is designed to allow vascular and cardiothoracic surgeons to achieve maximum effectiveness while greatly reducing the time and complexity of current procedures in concert with a commitment to efficient health care delivery. Founded in 1987 by Norman Jaffe, Hancock Jaffe Laboratories is headquartered in Irvine, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $107.1M
- Funding stage: IPO
- Last round: Post-IPO Equity (Sep 2024)
- Ticker: nasdaq:NVNO
- Website: envveno.com
- Phone: 949-261-2900
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Life Science, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/envveno-medical-corporation-178491 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.